Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Hypertension (Dallas, Tex. : 1979)|February 13, 2026
Aldosterone and the Mineralocorticoid Receptor in Atrial FibrillationArgen Mamazhakypov, Remi Peyronnet, Achim LotherMethods in Molecular Biology (Clifton, N.J.)|April 2, 2016
A Bioreactor to Apply Multimodal Physical Stimuli to Cultured CellsJan-Christoph Edelmann, Lizzie Jones, Remi Peyronnet, et al.Functional Plant Biology : FPB|July 22, 2020
R-type anion channel activation is an essential step for ROS-dependent innate immune response in Arabidopsis suspension cellsJean Colcombet, Yves Mathieu, Remi Peyronnet, et al.Plos One|February 23, 2019
A potential key mechanism in ascending aortic aneurysm development: Detection of a linear relationship between MMP-14/TIMP-2 ratio and active MMP-2Ramona Schmitt, Anke Tscheuschler, Philipp Laschinski, et al.The Journal of Physiology|March 11, 2026
Electromechanical modelling and simulation of human-induced pluripotent stem cell-derived cardiomyocytes predict drug-induced contractility effectsMilda Folkmanaite, Xin Zhou, Andreas Koschinski, et al.Circulation Research|November 24, 2020
Beat-by-Beat Cardiomyocyte T-Tubule Deformation Drives Tubular Content ExchangeEva A Rog-Zielinska, Marina Scardigli, Remi Peyronnet, et al.Cells|May 10, 2024
Divergent and Compensatory Effects of BMP2 and BMP4 on the VSMC Phenotype and BMP4's Role in Thoracic Aortic Aneurysm DevelopmentDaniel Klessinger, Argen Mamazhakypov, Sophie Glaeser, et al.Frontiers in Cardiovascular Medicine|February 5, 2025
PCSK9-antibodies fail to block PCSK9-induced inflammation in macrophages and cannot recapitulate protective effects of PCSK9-deficiency in experimental myocardial infarctionSimon Rauterberg, Carmen Härdtner, Jennifer Hein, et al.Nature Cell Biology|October 3, 2019
The NSL complex maintains nuclear architecture stability via lamin A/C acetylationAdam Karoutas, Witold Szymanski, Tobias Rausch, et al.European Heart Journal|November 30, 2018
Transgenic short-QT syndrome 1 rabbits mimic the human disease phenotype with QT/action potential duration shortening in the atria and ventricles and increased ventricular tachycardia/ventricular fibrillation inducibilityKatja E Odening, Ilona Bodi, Gerlind Franke, et al.Pageof 2